Missing weekly cisplatin cycles was associated with worse OS in patients with head and neck cancers, particularly for those ...

A population-based study revealed treatment patterns among patients starting chemotherapy as first-line therapy for ...

The standard first-line treatment for SCLC is cisplatin or carboplatin in combination with etoposide. Patients who have relapsed or individuals who do not respond to first-line chemotherapy can be ...

D uring a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no difference in mortality rates among patients with advanced cancer ...

Whether this is partly a result of dose reductions of IP cisplatin, differences in infusion rate of IV paclitaxel, or crossover is unknown. Nonetheless, GOG 252 is the largest and best-performed study ...

The platinum chemotherapy shortage resulted in a modest absolute reduction in platinum use but no difference in mortality, data suggest.

Experts say a myriad of factors have contributed to the shortages, which this time have heavily affected two front-line therapies - carboplatin and cisplatin - used to treat a host of cancers ...

"Patients with castrate-resistant neuroendocrine prostate cancer are typically treated the same as other small cell cancer subtypes—with platinum-based therapeutics such as cisplatin and ...